Virginia Retirement Systems’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,700
Closed -$140K 1170
2022
Q3
$140K Buy
+11,700
New +$145K ﹤0.01% 1094
2022
Q1
$373K Buy
43,000
+7,200
+20% +$69.4K ﹤0.01% 926
2021
Q4
$405 Sell
35,800
-2,200
-6% -$26.1K ﹤0.01% 910
2021
Q3
$478K Buy
38,000
+2,000
+6% +$18.4K ﹤0.01% 797
2021
Q2
$292K Buy
36,000
+400
+1% +$3.47K ﹤0.01% 929
2021
Q1
$329K Buy
35,600
+900
+3% +$9.07K ﹤0.01% 971
2020
Q4
$336K Buy
+34,700
New +$342K ﹤0.01% 950

Other funds holding GOSS

Virginia Retirement Systems's GOSS Position: Q4 2022 in Review

Virginia Retirement Systems sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 11,700 shares — an estimated $140K sold.

Virginia Retirement Systems first reported a position in GOSS in Q4 2020 and held it in 7 quarters. The position peaked at $478K in Q3 2021. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Virginia Retirement Systems reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,700 Gossamer Bio shares in Q4 2022, an estimated $140K.
  • Virginia Retirement Systems first reported a position in Gossamer Bio in Q4 2020 and held it in 7 quarters.
  • Virginia Retirement Systems's Gossamer Bio position peaked at $478K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Virginia Retirement Systems's 13F filing for Q4 2022, filed 17 May 2023.